BACKGROUND AND PURPOSE: Slowly expanding/evolving lesions measured by conventional T1-weighted/T2-weighted brain MR imaging may contribute to progressive disability accumulation in MS. We evaluated the longitudinal change in myelin and axonal tissue integrity in white matter slowly expanding/evolving lesions by means of the magnetization transfer ratio and DTI radial diffusivity. MATERIALS AND METHODS: Slowly expanding/evolving lesions were detected within the Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex (SYNERGY) Phase 2 clinical trial dataset (NCT01864148), comprising patients with relapsing-remitting and secondary-progressive MS (n = 299) with T1-weighted/T2-weighted MR imaging at all trial time points (baseline to week 72). RESULTS: Compared with non-slowly expanding/evolving lesions (areas not classified as slowly expanding/evolving lesion) of baseline nonenhancing T2 lesions, slowly expanding/evolving lesions had a lower normalized magnetization transfer ratio and greater DTI radial diffusivity, both in patients with relapsing-remitting MS (n = 242) and secondary-progressive MS (n = 57, P < .001 for all). Although the changes with time in both the normalized magnetization transfer ratio and DTI radial diffusivity between slowly expanding/evolving lesions and non-slowly expanding/evolving lesions were positively correlated (P < .001), a decrease in the normalized magnetization transfer ratio and a greater increase in DTI radial diffusivity were observed in slowly expanding/evolving lesions versus non-slowly expanding/evolving lesions from baseline to week 72 in relapsing-remitting MS and secondary-progressive MS (P < .001 for all). CONCLUSIONS: Patterns of longitudinal change in the normalized magnetization transfer ratio and DTI radial diffusivity in slowly expanding/evolving lesions were consistent with progressive demyelination and tissue loss, as seen in smoldering white matter MS plaques.
RCT Entities:
BACKGROUND AND PURPOSE: Slowly expanding/evolving lesions measured by conventional T1-weighted/T2-weighted brain MR imaging may contribute to progressive disability accumulation in MS. We evaluated the longitudinal change in myelin and axonal tissue integrity in white matter slowly expanding/evolving lesions by means of the magnetization transfer ratio and DTI radial diffusivity. MATERIALS AND METHODS: Slowly expanding/evolving lesions were detected within the Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex (SYNERGY) Phase 2 clinical trial dataset (NCT01864148), comprising patients with relapsing-remitting and secondary-progressive MS (n = 299) with T1-weighted/T2-weighted MR imaging at all trial time points (baseline to week 72). RESULTS: Compared with non-slowly expanding/evolving lesions (areas not classified as slowly expanding/evolving lesion) of baseline nonenhancing T2 lesions, slowly expanding/evolving lesions had a lower normalized magnetization transfer ratio and greater DTI radial diffusivity, both in patients with relapsing-remitting MS (n = 242) and secondary-progressive MS (n = 57, P < .001 for all). Although the changes with time in both the normalized magnetization transfer ratio and DTI radial diffusivity between slowly expanding/evolving lesions and non-slowly expanding/evolving lesions were positively correlated (P < .001), a decrease in the normalized magnetization transfer ratio and a greater increase in DTI radial diffusivity were observed in slowly expanding/evolving lesions versus non-slowly expanding/evolving lesions from baseline to week 72 in relapsing-remitting MS and secondary-progressive MS (P < .001 for all). CONCLUSIONS: Patterns of longitudinal change in the normalized magnetization transfer ratio and DTI radial diffusivity in slowly expanding/evolving lesions were consistent with progressive demyelination and tissue loss, as seen in smoldering white matter MS plaques.
Authors: Martina Absinta; Pascal Sati; Matthew Schindler; Emily C Leibovitch; Joan Ohayon; Tianxia Wu; Alessandro Meani; Massimo Filippi; Steven Jacobson; Irene C M Cortese; Daniel S Reich Journal: J Clin Invest Date: 2016-06-06 Impact factor: 14.808
Authors: Diego Cadavid; Michelle Mellion; Raymond Hupperts; Keith R Edwards; Peter A Calabresi; Jelena Drulović; Gavin Giovannoni; Hans-Peter Hartung; Douglas L Arnold; Elizabeth Fisher; Richard Rudick; Sha Mi; Yi Chai; Jie Li; Yiwei Zhang; Wenting Cheng; Lei Xu; Bing Zhu; Susan M Green; Ih Chang; Aaron Deykin; Sarah I Sheikh Journal: Lancet Neurol Date: 2019-07-05 Impact factor: 44.182
Authors: Frederik Barkhof; Wolfgang Bruck; Corline J A De Groot; Elisabeth Bergers; Sandra Hulshof; Jeroen Geurts; Chris H Polman; Paul van der Valk Journal: Arch Neurol Date: 2003-08
Authors: Jacqueline T Chen; D Louis Collins; Harold L Atkins; Mark S Freedman; Douglas L Arnold Journal: Ann Neurol Date: 2008-02 Impact factor: 10.422
Authors: Colm Elliott; Jerry S Wolinsky; Stephen L Hauser; Ludwig Kappos; Frederik Barkhof; Corrado Bernasconi; Wei Wei; Shibeshih Belachew; Douglas L Arnold Journal: Mult Scler Date: 2018-12-19 Impact factor: 6.312
Authors: Kunio Nakamura; Nicolas Guizard; Vladimir S Fonov; Sridar Narayanan; D Louis Collins; Douglas L Arnold Journal: Neuroimage Clin Date: 2013-10-29 Impact factor: 4.881
Authors: Joana Machado-Santos; Etsuji Saji; Anna R Tröscher; Manuela Paunovic; Roland Liblau; Galina Gabriely; Christian G Bien; Jan Bauer; Hans Lassmann Journal: Brain Date: 2018-07-01 Impact factor: 15.255
Authors: Vanessa Beynon; Ilena C George; Colm Elliott; Douglas L Arnold; Jun Ke; Huaihou Chen; Li Zhu; Chunlei Ke; Gavin Giovannoni; Matthew Scaramozza; Nolan Campbell; Daniel P Bradley; Nathalie Franchimont; Arie Gafson; Shibeshih Belachew Journal: BMJ Neurol Open Date: 2022-06-07
Authors: A Dal-Bianco; R Schranzer; G Grabner; M Lanzinger; S Kolbrink; G Pusswald; P Altmann; M Ponleitner; M Weber; B Kornek; K Zebenholzer; C Schmied; T Berger; H Lassmann; S Trattnig; S Hametner; F Leutmezer; P Rommer Journal: Front Neurol Date: 2021-12-21 Impact factor: 4.003
Authors: Shannon Kolind; Shawna Abel; Carolyn Taylor; Roger Tam; Cornelia Laule; David K B Li; Hideki Garren; Laura Gaetano; Corrado Bernasconi; David Clayton; Irene Vavasour; Anthony Traboulsee Journal: Neuroimage Clin Date: 2022-07-19 Impact factor: 4.891
Authors: Samuel Klistorner; Michael H Barnett; John Parratt; Con Yiannikas; Stuart L Graham; Alexander Klistorner Journal: Ann Clin Transl Neurol Date: 2022-09-03 Impact factor: 5.430